Preliminary Findings From a Prospective Cohort Study of Tirzepatide in Adults With Obesity and Heart Failure With Preserved Ejection Fraction: Longitudinal Effectiveness, Cardiometabolic Response, and Gastrointestinal Tolerability in Kazakhstan
Background: Evidence describing the longitudinal effectiveness and tolerability of tirzepatide in adults with obesity and heart failure with preserved ejection fraction (HFpEF) remains limited, particularly from prospective cohorts with repeated cardiometabolic assessments. This study evaluated longitudinal changes in...